LuminUltra Headquarters

LuminUltra Will Supply 500,000 COVID-19 tests per week to Canadian Government

April 15th, 2020

Fredericton, New Brunswick – Canadian biotechnology leader LuminUltra today announced that it will provide 500,000 urgently needed COVID-19 tests per week to the Canadian federal government for use across Canada.

In his press conference earlier today, Prime Minister Justin Trudeau announced that New Brunswick-based LuminUltra is ramping up its production capacity to provide tests for the provinces and territories.

“We responded immediately to the Prime Minister’s call to action to join in the fight against this virus by refocusing our team to develop the tests needed for COVID-19,” said LuminUltra Chairman and CEO Pat Whalen. “By producing and delivering 500,000 tests per week that leverage the existing testing infrastructure, we are essentially providing one test for every Canadian as a crucial step towards defeating the pandemic, protecting Canadians and alleviating the human cost of this disease.”

Recognized internationally as a leader in rapid-results biological testing, LuminUltra has the specialized tools and talent needed to produce the tests quickly, accurately and in large quantities. The company is well positioned from both a manufacturing and financial perspective to ramp up production to meet this growing demand. Shipment of these tests has already begun, and the pace will continue for the year ahead.

Added Whalen: “Our team at LuminUltra is very proud to be able to help Canadians during this incredibly difficult time for our country. Given our expertise in biological testing for environmental applications it is a natural extension for us to develop a test for COVID-19. We are grateful to have had the opportunity to work alongside the team at the Public Health Agency of Canada over the past few weeks, whose tireless work in protecting our country has been an inspiration.”

About LuminUltra

LuminUltra is a Canadian biotech company with more than 20 years’ experience in developing and delivering rapid-results biological testing primarily used to test environmental applications such as water. The company has dozens of Fortune 500 customers, sales in over 80 countries and operations in six countries.

At the same time, LuminUltra fosters a culture of innovation and agility and is on an accelerated growth path, acquiring multiple companies in recent years and forming a partnership with the specialized private equity firm XPV Water Partners. It is this innovation, agility and partnership which positioned the company to respond to Prime Minister Trudeau’s call to action to join in the fight against COVID-19.

Media Contact
Jessica Stutt
jessica.stutt@luminultra.com
1-250-609-0215


LuminUltra Team

Founded in 1995, LuminUltra is a molecular biology diagnostic testing company headquartered in Canada with operations in 6 countries. It is widely recognized globally as a leader in developing tests and reagents for environmental, industrial, and diagnostic monitoring applications and is a key supplier of COVID-19 diagnostic testing reagents to the Government of Canada.

Dozens of Fortune 500 customers across more than 80 countries trust LuminUltra’s technology, production reliability and history of customer service excellence to deliver their essential services in a safe state.

Related Posts

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now